Smartphone test predicts development of Parkinson’s symptoms, study says

News

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Researchers have created a smartphone test that may be able to predict the development of Parkinson’s symptoms.

The study – carried out by researchers from the University of Oxford and funded by the Monument Trust Discovery Award from charity Parkinson’s UK – used the test to assess voice, balance, walking and reaction time in people living with Parkinson’s.

The results indicated that the test may be able to predict development of Parkinson’s symptoms up to 18 months before they occur. Researchers hope this will allow healthcare professionals to tailor a more personalised approach to the treatment of Parkinson’s.

Christine Lo, clinical research fellow at the University of Oxford’s Oxford Parkinson’s Disease Centre, said: “The main driver for this study was to improve clinical care by finding better ways of predicting how Parkinson’s is likely to progress over time on an individual basis, as its course can vary greatly from person to person.”

To read more on this topic click here.

Five of our favourite apps for people with Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

In my country

“When coronavirus broke out in Europe, Italy was the hardest hit nation”

We talk to the founder of the European Parkinson Therapy Centre in Italy

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Campaigners win petition for ‘student carer’ status on uni application forms

Student carers soon to be recognised on application forms

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease. BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition. António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide. “The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Smartphone test predicts development of Parkinson’s symptoms, study says

News

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

In my country

“When coronavirus broke out in Europe, Italy was the hardest hit nation”

Resources & Tools

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Carers' Corner

Campaigners win petition for ‘student carer’ status on uni application forms

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Smartphone test predicts development of Parkinson’s symptoms, study says

News

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

In my country

“When coronavirus broke out in Europe, Italy was the hardest hit nation”

Resources & Tools

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Carers' Corner

Campaigners win petition for ‘student carer’ status on uni application forms

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Sign in